A study for skin condition by intake a food to be examined by UV irradiation. -A placebo-controlled, randomized, double-blind, cross-over trial
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000039082
- Lead Sponsor
- KSO Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Not provided
(1) Subjects who have been diagnosed with photosensitivity. (2) Subjects taking drugs that affect skin photosensitivity. (3) Subjects who are currently visiting a dermatologist or are being treated for other diseases. (4) Subjects with a history of sugar metabolism, lipid metabolism, liver function, renal function, heart, cardiovascular, respiratory and endocrine systems. (5) Subjects who regularly take medicines or health foods that are said to have moisturizing and whitening effects. (6) Subjects with symptoms of atopic dermatitis. (7) Subjects with significant abnormal skin condition at the test site, or subjects with sunburn. (8) Subjects with severe hay fever symptoms. (9) Subjects who continuously use or take anti-inflammatory drugs at least once a month. (10)Subjects who are using or taking drugs such as oral or liniment because of rough skin. (11) Subjects with food allergies to olive-containing foods. (12) Night shift worker or day and night shift workers. (13) Subjects with a digestive organ disease or surgical history that has an influence on digestive absorption. (14) Subjects who are judged to be inappropriate as subjects from the answers to the subject background questionnaire. (15) Subjects who are pregnant or breast-feeding, or have the will of pregnancy during the study period. (16)Subjects who has a medical history or current medical history of drug dependence or alcohol dependence. (17) Subjects who have participated in similar UV irradiation studies within the last two years. (18)Subjects who participate in other human studies within the last 4 weeks or who plan to participate in other human studied during the period of this study. (19) Subjects who are judged as unsuitable for the study by the investigator for the other reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. MED judgment by the responsible or assigned doctor. 2. Stratum corneum moisture content. 3. Skin viscoelasticity.
- Secondary Outcome Measures
Name Time Method Conduct VAS on the skin every week during the intake period (9 times in total) for: Skin viscoelasticity, Skin clarity, Youthfulness (visual impression), Improvement of rough skin, Improvement of fine wrinkles, improvement of dull skin, Improvement of laugh line.